Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines (Q39423669)

11 September 2017

Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines (English)

1 reference

head and neck squamous cell carcinoma

11 September 2017

0 references

1 reference

7

1 reference

11 September 2017

Goro Oshima

1

1 reference

11 September 2017

Johan Wennerberg

2

1 reference

11 September 2017

Takashi Yamatodani

3

1 reference

11 September 2017

Elisabeth Kjellén

4

1 reference

11 September 2017

Hiroyuki Mineta

5

1 reference

11 September 2017

Anders Johnsson

6

1 reference

11 September 2017

23 December 2011

1 reference

Journal of Cancer Research and Clinical Oncology

11 September 2017

1 reference

11 September 2017

138

1 reference

11 September 2017

3

1 reference

11 September 2017

491-499

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-011-1127-5

11 September 2017

0 references

cites work

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

PET of EGFR antibody distribution in head and neck squamous cell carcinoma models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

STAT signaling in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Platinum-based chemotherapy plus cetuximab in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Coomassie staining as loading control in Western blot analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-011-1127-5

Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells

21 January 2018

1 reference

12 December 2020

EGFR-targeting monoclonal antibodies in head and neck cancer

1 reference

12 December 2020

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

12 December 2020

Basolateral targeting and efficient consumption of transforming growth factor-alpha when expressed in Madin-Darby canine kidney cells

1 reference

12 December 2020

Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells

1 reference

12 December 2020

Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.

1 reference

12 December 2020

Expression and regulation of c-ERBB ligands in human head and neck squamous carcinoma cells

1 reference

12 December 2020

10.1007/S00432-011-1127-5

Identifiers

DOI

1 reference

11 September 2017

1 reference